Monitor for further selling by Millennium or other large holders. The reduction by a major hedge fund could signal waning conviction ahead of upcoming catalysts (e.g., regulatory decisions, pipeline data).
Price Chart
Executive Summary
Millennium Management LLC filed an amended Schedule 13G disclosing a passive stake of 2.9% (1,669,083 shares) in Capricor Therapeutics as of September 30, 2026. The filing confirms a reduction from the prior filing's stake, indicating Millennium is reducing its position. The filing explicitly certifies passive intent under Rule 13d-1(c).
Key Financial Metrics
Key Facts
- Millennium Management LLC reported beneficial ownership of 1,669,083 shares of Capricor Therapeutics common stock as of September 30, 2026.
- The stake represents 2.9% of shares outstanding.
- The filing is an amendment to a prior Schedule 13G, indicating a reduction from the previous position.
- The filing certifies passive intent under Rule 13d-1(c) — no activist conversion.
- Millennium Group Management LLC and Israel A. Englander are also named as joint filers with identical share counts.
Financial Impact
Millennium reduced its stake in Capricor Therapeutics to 2.9% (1,669,083 shares) as of September 30, 2026, down from a larger prior position.
Risk Factors
- Continued institutional selling pressure if other funds follow Millennium's lead.
- Potential negative signal about near-term prospects for Capricor's pipeline or commercial outlook.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-115876 |
| Document: 0001104659-26-115876-index-headers.html | 0001104659-26-115876 |
| Document: 0001104659-26-115876-index.html | 0001104659-26-115876 |
| Document: 0001104659-26-115876.txt | 0001104659-26-115876 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | SC 13G/A | $7.27 $6.13 | ▲ +15.68% | ▲ +14.67% | $5.89 (+18.98%) |
Aug 24, 2026 9w ago | 8-K | $6.80 $9.91 | ▼ −45.74% | ▼ −45.27% | $5.89 (+13.38%) |
Aug 21, 2026 9w ago | Institutional Cluster | $6.29 $9.59 | ▲ +52.46% | ▲ +51.99% | $5.89 (−6.36%) |
Jul 30, 2026 12w ago | Press Release | $4.19 $4.18 | ▲ +0.24% | ▲ +3.86% | $5.89 (−40.57%) |
Jul 14, 2026 14w ago | 8-K | $20.35 $18.91 | ▼ −7.08% | ▼ −6.10% | $5.89 (−71.06%) |
Jun 29, 2026 17w ago | Insider Cluster | $24.08 $22.43 | ▼ −6.85% | ▼ −7.46% | $5.89 (−75.54%) |
Jun 26, 2026 17w ago | 8-K | $23.80 $22.43 | ▼ −5.76% | ▼ −7.14% | $5.89 (−75.25%) |
Jun 24, 2026 17w ago | Insider Cluster | $30.40 $23.07 | ▼ −24.11% | ▼ −25.67% | $5.89 (−80.63%) |
Jun 1, 2026 21w ago | Court Ruling | $27.34 $26.01 | ▼ −4.86% | ▼ −1.90% | $5.89 (−78.46%) |
May 12, 2026 23w ago | Press Release | $30.33 $26.92 | ▼ −11.24% | ▼ −10.09% | $5.89 (−80.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers